-
R337829-250mg
RG-13022 (C007B-257749)
Price: $1,678.26List Price: $1,864.73RG-13022 is a Tyrosine kinase tyrphostin. Reports indicate that RG-13022 suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies. Additionally, RG-13022 has been described to inhibit EGF, platelet-dervied -
R337829-25mg
RG-13022 (C007B-257750)
Price: $346.12List Price: $384.58RG-13022 is a Tyrosine kinase tyrphostin. Reports indicate that RG-13022 suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies. Additionally, RG-13022 has been described to inhibit EGF, platelet-dervied -
10010309-10
RG-13022-10 mg
Price: $313.55List Price: $348.39An inhibitor of EGF receptor kinase with an IC50 value of 1 µM in HT-22 cells. -
10010309-50
RG-13022-50 mg
Price: $1,036.98List Price: $1,152.20An inhibitor of EGF receptor kinase with an IC50 value of 1 µM in HT-22 cells. -
SML3454-5MG
RIDAFOROLIMUS (C005B-308963)
Price: $177.34List Price: $197.04Biochem/physiol Actions Ridaforolimus is an antiproliferative mTOR inhibitor that forms a complex with the FK506 binding protein-12 (FKBP-12), which binds to and inhibits mTOR resulting in cell cycle arrest and inhibition of tumor cell growth and -
SML3454-25MG
RIDAFOROLIMUS (C005B-308964)
Price: $532.92List Price: $592.13Biochem/physiol Actions Ridaforolimus is an antiproliferative mTOR inhibitor that forms a complex with the FK506 binding protein-12 (FKBP-12), which binds to and inhibits mTOR resulting in cell cycle arrest and inhibition of tumor cell growth and -
R408473-1ml
Ridaforolimus (Deforolimus, MK-8669) (C007B-258397)
Price: $690.69List Price: $767.43InformationRidaforolimus (Deforolimus, MK-8669) Ridaforolimus (Deforolimus, MK-8669, AP23573) is a selective mTOR inhibitor with IC50 of 0.2 nM in HT-1080 cell line: while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to -
S3567-25MG
SB 415286 (C005B-369582)
Price: $1,362.16List Price: $1,513.51Application SB 415286 was used to treat neuroblastoma cells and study the effect of GSK-3 inhibition on cell proliferation. Biochem/physiol Actions SB 415286 is a small molecule inhibitor of GSK-3 in muscle and fat cells. -
SML1192-5MG
SB290157 TRIFLUOROACETATE SALT (C005B-312427)
Price: $248.76List Price: $276.40Biochem/physiol Actions SB290157 is a selective antagonist of complement anaphylatoxin C3a receptor, a 74 amino acid proinflammatory peptide that is a potent chemotaxin for eosinophils, macrophages and mast cells, and has recently been found to be -
SML1192-25MG
SB290157 TRIFLUOROACETATE SALT (C005B-312428)
Price: $774.64List Price: $860.71Biochem/physiol Actions SB290157 is a selective antagonist of complement anaphylatoxin C3a receptor, a 74 amino acid proinflammatory peptide that is a potent chemotaxin for eosinophils, macrophages and mast cells, and has recently been found to be -
009-001-T38
SMAD2 recombinant protein-GST fusion protein, 50 g
Price: $1,346.86List Price: $1,496.51SMAD2 Protein is stored in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0. -
SML2662-5MG
SPA70 (C005B-310309)
Price: $302.25List Price: $335.84Biochem/physiol Actions SPA70 is a cell penetrant, potent and highly selective human pregnane X receptor (hPXR) antagonist that inhibits hPXR in humanized mouse models. It inhibits hPXR-mediated drug metabolism in in primary human hepatocytes and